Almoosa Health Co. (4018)
Tadawul
118.00
+2.50 (+2.16%)
Real-time Data
07:00 AM
Day's Range
115.00118.00
52 wk Range
110.00212.00
Financial Statements - 4018 - Almoosa Health Co.
Revenue
1.41B
Net Income
236.54MNet Margin 16.7%
EBITDA
332.07M
Free Cash Flow
-350.20M
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 1.41B |
| Cost of Goods | 967.68M |
| Gross Profit | 448.59M |
 Operating Expense | - |
| Operating Income | 204.78M |
| Non-Operating Interest | - |
| Other Income Expense | - |
| Pre Tax Income | 240.71M |
| Income Tax | 4.17M |
| Net Income | 236.54M |
| EPS Basic | 5.36 |
| EPS Diluted | 5.36 |
| Basic Shares Outstanding | 44.15M |
| Diluted Shares Outstanding | 44.15M |
| Ebit | 264.74M |
| Ebitda | 332.07M |
| Net Income Continuous Operations | 240.71M |
| Minority Interests | - |
| Preferred Stock Dividends | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
